Results 221 to 230 of about 568,663 (342)

Peripheral T-Cell Lymphoma: What's Next? [PDF]

Hematol Oncol
Yoon SE, Kim WS.
europepmc   +1 more source

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, EarlyView.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

A Masked Intruder: Extranodal Natural Killer/T-Cell Lymphoma Mimicking Preseptal Cellulitis. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Fuentes SA, Griepentrog GJ, King RL, Bennani NN, Chesdachai S.   +4 more
europepmc   +1 more source

Estimating the survival impact of not receiving CAR T-cell (CAR T) therapy when eligible in patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) in the United States (US) [PDF]

Frederick L. Locke, Bradley Kievit, Genevieve Meier, Rob Blissett, Hil Hsu, Emily Boller, David Cobley, Mark Ray, Olalekan O. Oluwole   +8 more
openalex   +1 more source

Enteropathy-associated T cell lymphoma as a complication of longstanding celiac disease [PDF]

, 2017
Melika Hosseina, Constantine A. Soulellis, Alan Barkun   +2 more
openalex   +1 more source

Direct Extracellular Matrix Modulation Attenuates Intestinal Fibrosis via a Fibronectin‐Targeted Approach

Advanced Science, EarlyView.
Fibronectin regulates the extracellular matrix (ECM)–myofibroblast cycle through three key steps: (1) its secretion and assembly by myofibroblasts (inhibited by pUR4); (2) collagen deposition along its scaffold (inhibited by R1R2); and (3) integrin α5β1‐mediated mechanotransduction (inhibited by ATN161).
Wenlong Ma, Siyu Yang, Tengkai Wang, Di Zhang, Hewei Wu, Shichen Fu, Xiaohan Wan, Lixiang Li, Xiuli Zuo, Yanqing Li, Jiaoyang Lu   +10 more
wiley   +1 more source

Diagnosis and Treatment of Laryngeal Extranodal Natural Killer/T-cell Lymphoma. [PDF]

Cureus
Quispe-Villegas G, Custodio Y, Aliaga R.
europepmc   +1 more source

Liposomal mitoxantrone versus chidamide in relapsed/refractory peripheral T-cell lymphoma: Final analysis from the multicenter, prospective randomized phase 3 study [PDF]

Yan Gao, Huijing Wu, Qingyuan Zhang, Yu Yang, Zengjun Li, Hui Zhou, Yajun Li, Zhifeng Li, Aimin Zang, Xun Lai, Weiping Tao, Fei Li, Zhihua Yao, Jie Cui, Yao Liu, Liping Su, Liling Zhang, Yanping Liu, Jing Shi, Lingjun Xin, Chuanchuan Wang, Yitao Wang, Hui-Qiang Huang   +22 more
openalex   +1 more source

Cutaneous T-cell lymphoma

Indian Journal of Medical Research, 2020
Arora, Shalabh, Gogia, Ajay
openaire   +2 more sources

CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring

Advanced Science, EarlyView.
This study identifies POLD4 as a potential prostate cancer radiosensitization target through transcriptome sequencing. By encapsulating POLD4‐targeted CRISPR/Cas9 plasmids and USPIONs in cationic liposomes, an MRI‐monitored gene‐editing platform is established.
Xuhui Fan, Ruru Zhang, Linjun Yang, Shixiong Chen, Meijuan He, Yongqiang Wang, Linjie Huang, Jianfeng Zeng, Shuwang Wu, Mingyuan Gao, Han Wang   +10 more
wiley   +1 more source